TY - JOUR
T1 - Implementing core outcomes in kidney disease
T2 - report of the Standardized Outcomes in Nephrology (SONG) implementation workshop
AU - SONG Implementation Workshop Investigators
AU - Tong, Allison
AU - Manns, Braden
AU - Wang, Angela Yee Moon
AU - Hemmelgarn, Brenda
AU - Wheeler, David C
AU - Gill, John
AU - Tugwell, Peter
AU - Pecoits-Filho, Robert
AU - Crowe, Sally
AU - Harris, Tess
AU - Van Biesen, Wim
AU - Winkelmayer, Wolfgang C
AU - Levin, Adeera
AU - Thompson, Aliza
AU - Perkovic, Vlado
AU - Ju, Angela
AU - Gutman, Talia
AU - Bernier-Jean, Amelie
AU - Viecelli, Andrea K
AU - O'Lone, Emma
AU - Shen, Jenny
AU - Josephson, Michelle A
AU - Cho, Yeoungjee
AU - Johnson, David W
AU - Sautenet, Bénédicte
AU - Tonelli, Marcello
AU - Craig, Jonathan C
N1 - Copyright © 2018 International Society of Nephrology. All rights reserved.
PY - 2018/12
Y1 - 2018/12
N2 - There are an estimated 14,000 randomized trials published in chronic kidney disease. The most frequently reported outcomes are biochemical endpoints, rather than clinical and patient-reported outcomes including cardiovascular disease, mortality, and quality of life. While many trials have focused on optimizing kidney health, the heterogeneity and uncertain relevance of outcomes reported across trials may limit their policy and practice impact. The international Standardized Outcomes in Nephrology (SONG) Initiative was formed to identify core outcomes that are critically important to patients and health professionals, to be reported consistently across trials. We convened a SONG Implementation Workshop to discuss the implementation of core outcomes. Eighty-two patients/caregivers and health professionals participated in plenary and breakout discussions. In this report, we summarize the findings of the workshop in two main themes: socializing the concept of core outcomes, and demonstrating feasibility and usability. We outline implementation strategies and pathways to be established through partnership with stakeholders, which may bolster acceptance and reporting of core outcomes in trials, and encourage their use by end-users such as guideline producers and policymakers to help improve patient-important outcomes.
AB - There are an estimated 14,000 randomized trials published in chronic kidney disease. The most frequently reported outcomes are biochemical endpoints, rather than clinical and patient-reported outcomes including cardiovascular disease, mortality, and quality of life. While many trials have focused on optimizing kidney health, the heterogeneity and uncertain relevance of outcomes reported across trials may limit their policy and practice impact. The international Standardized Outcomes in Nephrology (SONG) Initiative was formed to identify core outcomes that are critically important to patients and health professionals, to be reported consistently across trials. We convened a SONG Implementation Workshop to discuss the implementation of core outcomes. Eighty-two patients/caregivers and health professionals participated in plenary and breakout discussions. In this report, we summarize the findings of the workshop in two main themes: socializing the concept of core outcomes, and demonstrating feasibility and usability. We outline implementation strategies and pathways to be established through partnership with stakeholders, which may bolster acceptance and reporting of core outcomes in trials, and encourage their use by end-users such as guideline producers and policymakers to help improve patient-important outcomes.
KW - Consensus
KW - Endpoint Determination/standards
KW - Humans
KW - Randomized Controlled Trials as Topic/standards
KW - Renal Insufficiency, Chronic/diagnosis
KW - Research Design/standards
KW - Stakeholder Participation
KW - Treatment Outcome
U2 - 10.1016/j.kint.2018.08.018
DO - 10.1016/j.kint.2018.08.018
M3 - Article
C2 - 30360959
SN - 0085-2538
VL - 94
SP - 1053
EP - 1068
JO - Kidney International
JF - Kidney International
IS - 6
ER -